Free Trial

Aptevo Therapeutics (APVO) SEC Filings & 10K Form

Aptevo Therapeutics logo
$0.31 +0.04 (+14.94%)
(As of 11/22/2024 ET)

Recent Aptevo Therapeutics SEC Filings

DateFilerForm TypeView
11/22/2024
7:45 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
7:45 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
1:57 PM
Aptevo Therapeutics (Subject)
Hudson Bay Capital Management LP (Filed by)
Form SC 13G
11/07/2024
7:30 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
7:15 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:48 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
09/18/2024
3:07 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
4:28 PM
Aptevo Therapeutics (Filer)
Form 424B4
09/16/2024
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
09/16/2024
7:09 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
4:26 PM
Aptevo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/09/2024
3:30 PM
Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:33 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:35 PM
Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:30 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:15 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:32 PM
Aptevo Therapeutics (Issuer)
Niederhuber John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:34 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:35 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:35 PM
Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:36 PM
Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:37 PM
Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:38 PM
Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:30 PM
Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:31 PM
Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
7:19 AM
Aptevo Therapeutics (Filer)
Form DEF 14A
07/12/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/03/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
06/30/2024
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
06/26/2024
7:30 AM
Aptevo Therapeutics (Filer)
Form S-1/A
06/14/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/10/2024
3:30 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
3:31 PM
Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
7:30 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
7:15 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:05 PM
Aptevo Therapeutics (Filer)
Form DEF 14A
04/23/2024
3:10 PM
Aptevo Therapeutics (Filer)
Form DEFA14A
04/23/2024
3:15 PM
Aptevo Therapeutics (Filer)
Form ARS
04/12/2024
4:23 PM
Aptevo Therapeutics (Filer)
Form 424B4
I hate to say I told you so (Ad)

Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…

04/10/2024
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
04/09/2024
4:26 PM
Aptevo Therapeutics (Filer)
Form S-1/A
03/29/2024
4:00 PM
Aptevo Therapeutics (Filer)
Form S-1/A
03/20/2024
3:15 PM
Aptevo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/07/2024
7:56 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:30 AM
Aptevo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
7:15 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:24 PM
Aptevo Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
02/06/2024
3:37 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
5:02 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:04 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:05 PM
Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:00 AM
Aptevo Therapeutics (Filer)
Form DEFR14A
12/12/2023
3:19 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
11/30/2023
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APVO) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners